Maria Velinova

1.4k total citations
32 papers, 853 citations indexed

About

Maria Velinova is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Maria Velinova has authored 32 papers receiving a total of 853 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Immunology and 8 papers in Oncology. Recurrent topics in Maria Velinova's work include Lipid Membrane Structure and Behavior (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Biosimilars and Bioanalytical Methods (6 papers). Maria Velinova is often cited by papers focused on Lipid Membrane Structure and Behavior (8 papers), Nanoparticle-Based Drug Delivery (6 papers) and Biosimilars and Bioanalytical Methods (6 papers). Maria Velinova collaborates with scholars based in United States, Netherlands and Bulgaria. Maria Velinova's co-authors include Alia Tadjer, Durba Sengupta, ‪Siewert J. Marrink, Gerrit L. Scherphof, Rutger W.H.M. Staffhorst, Ben de Kruijff, Peter M. Frederik, Paul H. H. Bomans, Koert N.J. Burger and J.J.L. van der Want and has published in prestigious journals such as Nature Medicine, Hepatology and The Journal of Physical Chemistry B.

In The Last Decade

Maria Velinova

31 papers receiving 823 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maria Velinova United States	16	345	239	161	158	125	32	853
Sathyamangalam V. Balasubramanian United States	17	543 1.6×	293 1.2×	80 0.5×	82 0.5×	164 1.3×	26	966
Cristina Delgado United Kingdom	16	929 2.7×	375 1.6×	123 0.8×	155 1.0×	253 2.0×	40	1.7k
Sandra Ward United States	15	600 1.7×	114 0.5×	365 2.3×	168 1.1×	56 0.4×	23	1.2k
André Ziegler Switzerland	18	1.2k 3.6×	216 0.9×	158 1.0×	95 0.6×	46 0.4×	35	1.8k
Harish M. Patel United Kingdom	19	488 1.4×	438 1.8×	79 0.5×	157 1.0×	97 0.8×	31	1.2k
Wentao Fu United States	15	474 1.4×	123 0.5×	146 0.9×	127 0.8×	398 3.2×	25	1.4k
T.E. Redelmeier Canada	15	845 2.4×	387 1.6×	47 0.3×	79 0.5×	146 1.2×	15	1.2k
Inna Solomonov Israel	22	644 1.9×	100 0.4×	161 1.0×	86 0.5×	353 2.8×	38	1.6k
Sara Pellegrino Italy	24	923 2.7×	284 1.2×	116 0.7×	585 3.7×	129 1.0×	124	1.7k
Jeanne Leblond Chain France	19	592 1.7×	243 1.0×	59 0.4×	241 1.5×	38 0.3×	44	1.1k

Countries citing papers authored by Maria Velinova

Since Specialization

Citations

This map shows the geographic impact of Maria Velinova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Velinova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Velinova more than expected).

Fields of papers citing papers by Maria Velinova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Velinova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Velinova. The network helps show where Maria Velinova may publish in the future.

Co-authorship network of co-authors of Maria Velinova

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Velinova. A scholar is included among the top collaborators of Maria Velinova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Velinova. Maria Velinova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghasemi, Mohammad, Ji Yun Kim, Lisa Seitz, et al.. (2025). Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants. British Journal of Clinical Pharmacology. 91(12). 3366–3377.

Voltz, Emilie, Ülrike Sommer, Elaine Tritto, et al.. (2024). First‐in‐human safety, tolerability, and pharmacokinetic results of DFV890, an oral low‐molecular‐weight NLRP3 inhibitor. Clinical and Translational Science. 17(5). e13789–e13789. 27 indexed citations

Shin, Donghoon, et al.. (2020). <p>Comparison of the Pharmacokinetics, Safety, and Tolerability of the Autoinjector (AI) and Pre-Filled Syringe (PFS) of SB4 in Healthy Subjects</p>. Drug Design Development and Therapy. Volume 14. 43–50. 1 indexed citations

Blumenstein, Lars, et al.. (2020). Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection. The AAPS Journal. 22(6). 134–134. 16 indexed citations

Richter, Oliver von, Rainard Fuhr, Thomas Koernicke, et al.. (2019). GP2017, an adalimumab biosimilar: pharmacokinetic similarity to its reference medicine and pharmacokinetics comparison of different administration methods. Expert Opinion on Biological Therapy. 19(10). 1075–1083. 28 indexed citations

Bradbury, Margaret, Orit Cohen‐Barak, Igor D. Grachev, et al.. (2018). Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects. British Journal of Clinical Pharmacology. 84(10). 2422–2432. 31 indexed citations

Jansen, Mendel, Domenico Merante, Alexander Currie, et al.. (2016). (403) Co-administration of mirogabalin and zolpidem in healthy subjects: results from a randomized, double-blind, drug-drug interaction study. Journal of Pain. 17(4). S75–S75. 1 indexed citations

Martin, Paul T., David M. Pierce, Mary Corcoran, et al.. (2015). A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults. Drug Design Development and Therapy. 9. 1257–1257. 4 indexed citations

Velinova, Maria, Durba Sengupta, Alia Tadjer, & ‪Siewert J. Marrink. (2011). Sphere-to-Rod Transitions of Nonionic Surfactant Micelles in Aqueous Solution Modeled by Molecular Dynamics Simulations. Langmuir. 27(23). 14071–14077. 131 indexed citations

10.

Velinova, Maria, et al.. (2010). Boron–nitrogen- and boron-substituted anthracenes and -phenanthrenes as models for doped carbon-based materials. Journal of Molecular Structure THEOCHEM. 955(1-3). 97–108. 7 indexed citations

11.

Velinova, Maria. (2004). Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1663(1-2). 135–142. 1 indexed citations

12.

Velinova, Maria, Rutger W.H.M. Staffhorst, Willem J. M. Mulder, et al.. (2004). Preparation and stability of lipid-coated nanocapsules of cisplatin: anionic phospholipid specificity. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1663(1-2). 135–142. 26 indexed citations

13.

Cartier, Régis, et al.. (2003). Ultrastructural Analysis of DNA Complexes During Transfection and Intracellular Transport. Journal of Histochemistry & Cytochemistry. 51(9). 1237–1240. 4 indexed citations

14.

Burger, Koert N.J., Rutger W.H.M. Staffhorst, Maria Velinova, et al.. (2002). Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity. Nature Medicine. 8(1). 81–84. 159 indexed citations

15.

Kamps, Jan A. A. M., Gerben A. Koning, Maria Velinova, et al.. (2000). Uptake of Long-Circulating Immunoliposomes, Directed Against Colon Adenocarcinoma Cells, by Liver Metastases of Colon Cancer. Journal of drug targeting. 8(4). 235–245. 36 indexed citations

16.

Koning, Gerben A., Henriëtte W. M. Morselt, Maria Velinova, et al.. (1999). Selective transfer of a lipophilic prodrug of 5-fluorodeoxyuridine from immunoliposomes to colon cancer cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1420(1-2). 153–167. 66 indexed citations

17.

Oussoren, Christien, Maria Velinova, Gerrit L. Scherphof, et al.. (1998). Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1370(2). 259–272. 71 indexed citations

18.

Scherphof, Gerrit L., Maria Velinova, Jan A. A. M. Kamps, et al.. (1997). Modulation of pharmacokinetic behavior of liposomes. Advanced Drug Delivery Reviews. 24(2-3). 179–191. 30 indexed citations

19.

Daemen, Toos, et al.. (1997). Different intrahepatic distribution of phosphatidylglycerol and phosphatidylserine liposomes in the rat. Hepatology. 26(2). 416–423. 54 indexed citations

20.

Velinova, Maria, N G Read, Christopher Kirby, & Gregory Gregoriadis. (1996). Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1299(2). 207–215. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact